temozolomide has been researched along with az10606120 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drill, M; Drummond, KJ; Galea, E; Hunn, M; Jayakrishnan, PC; Kan, LK; Monif, M; O'Brien, TJ; Sanfilippo, PG; Sequeira, RP; Todaro, M; Williams, DA | 1 |
1 other study(ies) available for temozolomide and az10606120
| Article | Year |
|---|---|
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma.
Topics: Adamantane; Aminoquinolines; Glioblastoma; Humans; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Temozolomide; Tumor Microenvironment | 2023 |